Browsing by Author Bernhard, Jurg

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 13 of 13
Issue DateTitleAuthor(s)Citation
2016Adjuvant tamoxifen plus ovarian function suppression versus tamoxifen alone in premenopausal women with early breast cancer: Patient-reported outcomes in the suppression of ovarian function trialCoates, Alan; Bellet, Meritxell; Bernhard, Jurg; Burstein, Harold J.; Ciruelos, Eva; et al, Various; Francis, Prudence; Lluch, Ana; Luo, Weixiu; Pavesi, Lorenzo; Ribi, Karin; School of Public Health: Public HealthAdjuvant tamoxifen plus ovarian function suppression versus tamoxifen alone in premenopausal women with early breast cancer: Patient-reported outcomes in the suppression of ovarian function trial, Journal of Clinical Oncology, vol.34, 14, 2016,pp 1601-1610
2016Adjuvant tamoxifen plus ovarian function suppression versus tamoxifen alone in premenopausal women with early breast cancer: Patient-reported outcomes in the suppression of ovarian function trialCoates, Alan; Bellet, Meritxell; Bernhard, Jurg; Burstein, Harold J.; Ciruelos, Eva; et al, Various; Francis, Prudence; Lluch, Ana; Luo, Weixiu; Pavesi, Lorenzo; Ribi, Karin; School of Public Health: Public HealthAdjuvant tamoxifen plus ovarian function suppression versus tamoxifen alone in premenopausal women with early breast cancer: Patient-reported outcomes in the suppression of ovarian function trial, Journal of Clinical Oncology, vol.34, 14, 2016,pp 1601-1610
2011Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trialCoates, Alan; Aldridge, Julie; Bernhard, Jurg; Cardoso, Fatima; Gelber, RD; Goldhirsch, Aron (Prof); Harvey, V; Pagani, O.; Phillips, Kelly-Anne; Price, K N; Ribi, Karin; Sun, Zhuoxin; Thompson, Alastair; Thurlimann, B.; School of Public Health: Public HealthCognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial, Breast Cancer Research and Treatment, vol.126, 1, 2011,pp 221-226
2010Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trialCoates, Alan; Bernhard, Jurg; Cardoso, Fatima; Gelber, Richard D. (Prof); Goldhirsch, A; Harvey, V; Pagani, O.; Phillips, Kelly-Anne; Price, Karen; Ribi, Karen; Stephens, Alisa; Sun, Zhuoxin; Thompson, Alastair; Thurlimann, B.; School of Public Health: Public HealthCognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial, The Breast, vol.19, 5,pp 388-395
2012Communication about standard treatment options and clinical trials: can we teach doctors new skills to improve patient outcomes?Butow, Phyllis; Juraskova, Ilona; Aldridge, Julie; Bernhard, Jurg; Brown, Richard; Ribi, Karin; Psychology; PsychologyCommunication about standard treatment options and clinical trials: can we teach doctors new skills to improve patient outcomes?, Psycho-Oncology: journal of the psychological, social and behavioral dimensions of cancer, vol.21, 12, 2012,pp 1265-1274
2006Impact of Adjuvant Chemotherapy Followed By Goserelin Compared With Either Modality Alone on Amenorrhea, Hot Flashes, and Quality of Life in Premenopausal Patients With Lymph Node-Negative Breast Cancer: Results on the Effect of Age From the InternationalCoates, Alan; Aebi, Stefan; Bernhard, Jurg; Castiglione-Gertsch, Monica; Collins, John; et, al; Forbes, J; Gelber, Richard D. (Prof); Hurny, Christoph; Murray, E.; Zahrieh, David; School of Public Health: Public HealthImpact of Adjuvant Chemotherapy Followed By Goserelin Compared With Either Modality Alone on Amenorrhea, Hot Flashes, and Quality of Life in Premenopausal Patients With Lymph Node-Negative Breast Cancer: Results on the Effect of Age From the International, JOURNAL OF CLINICAL ONCOLOGY 2005, vol.25,(3),2006,pp 263-270
2012Meeting the Decision-Making Preferences of Patients With Breast Cancer in Oncology Consultations: Impact on Decision-Related OutcomesButow, Phyllis; Juraskova, Ilona; Bernhard, Jurg; Brown, Richard; Ribi, Karin; Wilson-Genderson, Maureen; Psychology; PsychologyMeeting the Decision-Making Preferences of Patients With Breast Cancer in Oncology Consultations: Impact on Decision-Related Outcomes, Journal of Clinical Oncology, vol.30, 8, 2012,pp 857-862
2015Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trialsCoates, Alan; Bernhard, Jurg; Burstein, Harold J.; Colleoni, Marco; et al, Various; Luo, Weixiu; Pinotti, Graziella; Puglisi, Fabio; Ribi, Karin; Ruhstaller, Thomas; Spazzapan, Simon; Tondini, Carlo; School of Public Health: Public HealthPatient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials, The Lancet Oncology, vol.16, 7, 2015,pp 848-858
2006Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93.Coates, Alan; Bernhard, Jurg; Campbell, Ian; Crivellari, Diana; Dent, David; et, al; Forbes, John F.; Holmberg, Stig B.; Rey, Piercarlo; Rudenstam, Carl-Magnus; Zahrieh, David; School of Public Health: Public HealthRandomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93., JOURNAL OF CLINICAL ONCOLOGY 2005, vol.24,(3),2006,pp 337-344
2010Shared decision making coding systems: How do they compare in the oncology context?Butow, Phyllis; chang, Sarah; Juraskova, Ilona; Lopez, Anna-Lena; Bernhard, Jurg; Brown, Richard; Psychology; Psychology; Psychology; PsychologyShared decision making coding systems: How do they compare in the oncology context?, Patient Education and Counseling, vol.78, 2,pp 261-268
2011Sharing decisions in breast cancer care: Development of the Decision Analysis System for Oncology (DAS-O) to identify shared decision making during treatment consultationsButow, Phyllis; Juraskova, Ilona; Tattersall, Martin; Bernhard, Jurg; Brown, Richard; Gerber, Daniela; Ribi, Karin; Psychology; Psychology; Central Clinical School: MedicineSharing decisions in breast cancer care: Development of the Decision Analysis System for Oncology (DAS-O) to identify shared decision making during treatment consultations, Health expectations : an international journal of public participation in health care and health policy, vol.14, 1, 2011,pp 29-37
2011Sharing decisions in breast cancer care: Development of the Decision Analysis System for Oncology (DAS-O) to identify shared decision making during treatment consultationsButow, Phyllis; Juraskova, Ilona; Tattersall, Martin; Bernhard, Jurg; Brown, Richard; Gerber, Daniela; Ribi, Karin; Psychology; Psychology; Central Clinical School: MedicineSharing decisions in breast cancer care: Development of the Decision Analysis System for Oncology (DAS-O) to identify shared decision making during treatment consultations, Health Expectations, vol.14, 1, 2011,pp 29-37
2011Sharing vs. Caring - The relative impact of sharing decisions versus managing emotions on patient outcomesButow, Phyllis; Chang, Sarah; Juraskova, Ilona; Lopez, Anna-Lena; Miguel, Caroline; Smith, Allen; Bernhard, Jurg; Brown, Richard; Psychology; Psychology; Psychology; Psychology; Psychology; PsychologySharing vs. Caring - The relative impact of sharing decisions versus managing emotions on patient outcomes, Patient Education and Counseling, vol.82, 3, 2011,pp 233-239